MagneGas Provides Business Update for the Third Quarter of 2018
More than 195% Quarterly Revenue Increase from Last Year TAMPA, Fla., Nov. 14, 2018 (GLOBE NEWSWIRE) — MagneGas Applied Technology […]
RedHill Biopharma Announces Presentation on YELIVA® (opaganib) for Multiple Myeloma at EORTC-NCI-AACR Symposium
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) […]
Titan Machinery Inc. to Report Fiscal Third Quarter Ended October 31, 2018 Results on November 29, 2018
WEST FARGO, N.D., Nov. 14, 2018 (GLOBE NEWSWIRE) — Titan Machinery Inc. (Nasdaq: TITN) announced today it will release financial […]
Micron Unveils Secure NOR Flash Memory Solution to Accelerate and Authenticate Intelligence at the Edge
New Micron MT25Q NOR Flash Enabled with Authenta™ Technology Embeds Cyber Security into Standard Flash Memory, Reducing Costs and Time to […]
Vera Bradley Foundation for Breast Cancer Raises $2.2 million for Breast Cancer Research
FORT WAYNE, Ind., Nov. 14, 2018 (GLOBE NEWSWIRE) — The Vera Bradley Foundation for Breast Cancer (the “Foundation”) recently announced […]
Replimune Reports Financial Results for the Second Fiscal Quarter, Ended September 30, and Provides Development and Corporate Update
U.S. Clinical Sites for Phase 1/2 Trial of RP1 in Patients with Solid Tumors on Track to Initiate by End […]
Entasis Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update
Completed $75.0 million initial public offering in September Reported positive Phase 2 topline results of lead program ETX2514SUL On-track to […]
Cue Biopharma to Host Business Update Call and Webcast
CAMBRIDGE, Mass., Nov. 14, 2018 (GLOBE NEWSWIRE) — Cue Biopharma, Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, […]
Liquidia Technologies to Present LIQ865 Phase 1a Data at ASRA’s 17th Annual Pain Medicine Meeting
RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (Nasdaq:LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company […]
NanoVibronix Provides Business Update for the Third Quarter of 2018
Lays out key upcoming milestones for the next 12 months ELMSFORD, N.Y., Nov. 14, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, […]
